104 related articles for article (PubMed ID: 1366140)
1. [The effect of Tauredon on the development of non-specific indicators of inflammatory activity in patients with rheumatoid arthritis].
Vlak T; Jajić Z
Reumatizam; 1992; 39(1):19-22. PubMed ID: 1366140
[TBL] [Abstract][Full Text] [Related]
2. [The effect of 6 months of treatment with Tauredon on clinical indicators in rheumatoid arthritis].
Vlak T; Jajić I
Reumatizam; 1992; 39(1):27-31. PubMed ID: 1366142
[TBL] [Abstract][Full Text] [Related]
3. [Comparative study of the effects of auranofin and aurothiomalate on laboratory and clinical indicators in patients with rheumatoid arthritis].
Vlak T; Stambuk B
Reumatizam; 1998; 46(1):7-19. PubMed ID: 9921004
[TBL] [Abstract][Full Text] [Related]
4. [The effect of gold salts on rheumatoid factor dynamics in patients with rheumatoid arthritis].
Vlak T; Jajić I
Reumatizam; 1992; 39(1):11-3. PubMed ID: 1366138
[TBL] [Abstract][Full Text] [Related]
5. [Complement (C3 and C4) in patients with rheumatoid arthritis during 6 months of treatment with gold salts].
Vlak T; Jajić I
Reumatizam; 1992; 39(1):7-10. PubMed ID: 1366144
[TBL] [Abstract][Full Text] [Related]
6. [The effect of Na-aurothiomalate on circulating immune complex dynamics in patients with rheumatoid arthritis].
Vlak T; Jajić I
Reumatizam; 1992; 39(2):1-5. PubMed ID: 1366145
[TBL] [Abstract][Full Text] [Related]
7. [Side effects of gold salt therapy in patients with rheumatoid arthritis].
Vlak T; Jajić I
Reumatizam; 1992; 39(2):25-8. PubMed ID: 1366149
[TBL] [Abstract][Full Text] [Related]
8. [Parenteral gold therapy (Tauredon) in chronic polyarthritis].
Tausch G; Gaismayer K
Wien Klin Wochenschr Suppl; 1984; 156():19-21. PubMed ID: 6442051
[TBL] [Abstract][Full Text] [Related]
9. [Effect of combination therapy and nonsteroidal antirheumatic agents on acute phase reactants in patients with rheumatoid arthritis].
Berdnik-Gortan K; Bjelinski D
Reumatizam; 1999; 46(1):12-6. PubMed ID: 11552614
[TBL] [Abstract][Full Text] [Related]
10. [Phagocytic activity in rheumatoid arthritis].
Jelcić A; Car A; Gnjidić Z; Sabioncello A
Reumatizam; 1992; 39(2):17-9. PubMed ID: 1366147
[TBL] [Abstract][Full Text] [Related]
11. Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate.
Mallya RK; de Beer FC; Berry H; Hamilton ED; Mace BE; Pepys MB
J Rheumatol; 1982; 9(2):224-8. PubMed ID: 7097681
[TBL] [Abstract][Full Text] [Related]
12. [The Tauredon treatment of rheumatoid arthritis patients: its efficacy and tolerance when used long term].
Murav'ev IuV; Nasonova VA; Ivanova MM; Taukumova LA
Ter Arkh; 1996; 68(5):16-8. PubMed ID: 9082589
[No Abstract] [Full Text] [Related]
13. Interleukin-2 receptor levels in sera of patients with rheumatoid arthritis treated with sulfasalazine, parenteral gold, or placebo.
Merkel PA; Dooley MA; Dawson DV; Pisetsky DS; Polisson RP
J Rheumatol; 1996 Nov; 23(11):1856-61. PubMed ID: 8923356
[TBL] [Abstract][Full Text] [Related]
14. Influence of gold salts treatment on the serum concentration of IL-1 and IL-2 in patients with rheumatoid arthritis.
Lewandowicz J; Dabkowska B; Nowak D
Arch Immunol Ther Exp (Warsz); 1995; 43(3-4):195-8. PubMed ID: 8744695
[TBL] [Abstract][Full Text] [Related]
15. Response of rheumatoid arthritis with leukopenia to gold salts.
Gowans JD; Salami M
N Engl J Med; 1973 May; 288(19):1007-8. PubMed ID: 4633144
[No Abstract] [Full Text] [Related]
16. Gold therapy lowers serum interleukin 6 levels in rheumatoid arthritis.
Madhok R; Crilly A; Murphy E; Smith J; Watson J; Capell HA
J Rheumatol; 1993 Apr; 20(4):630-3. PubMed ID: 8496855
[TBL] [Abstract][Full Text] [Related]
17. [Studies of protein clearance in patients treated with and without gold preparations in rheumatoid arthritis].
Gräfenstein K
Z Gesamte Inn Med; 1987 Jan; 42(2):56-8. PubMed ID: 3107230
[TBL] [Abstract][Full Text] [Related]
18. Mucocutaneous side effects and continuation of aurotherapy in patients with rheumatoid arthritis.
Taukumova LA; Mouravjoy YuV ; Gribakin SG
Adv Exp Med Biol; 1999; 455():367-73. PubMed ID: 10599371
[TBL] [Abstract][Full Text] [Related]
19. The effect of antirheumatic drugs on circulating immune complexes in rheumatoid arthritis.
Forster PJ; McConkey B
Q J Med; 1986 Jan; 58(225):29-42. PubMed ID: 2871585
[TBL] [Abstract][Full Text] [Related]
20. [Comparative evaluation of the effectiveness of gold preparations and D-penicillamine and their tolerance in rheumatoid arthritis. I. The effect on the indicators of their activity and tolerance].
Slobodina GA; Kanevskaia MZ; Krel' AA; Chichasova NV
Revmatologiia (Mosk); 1989; (1):8-16. PubMed ID: 2501852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
